Cytokinetics Announces Presentation of Additional Analyses from Clinical Trials of Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis

Cytokinetics Announces Presentation of Additional Analyses from Clinical Trials of Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis

[at noodls] – Pharmacokinetics of Tirasemtiv Are Dose Proportional; Positive and Concentration Dependent Effects Were Observed on Multiple Functional Measures South San Francisco, CA – December 7, 2012 Cytokinetics, … more

View todays social media effects on CYTK

View the latest stocks trending across Twitter. Click to view dashboard

See who Cytokinetics is hiring next, click here to view

Share this post

Comments (0)